Latest news
No early success for Moderna’s norovirus vaccine in phase 3 trial - cidrap.umn.educidrap.umn.edu · Mon, 03 Aug 2026 18:09:00 GMTCocrystal Pharma Secures $5 Million Investment from OPKO Health as Norovirus Program Advances Toward Phase 1b Data - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMTModerna Says Norovirus Vaccine Didn’t Meet Statistical Criteria for Early Success in Trial - WSJWSJ · Fri, 31 Jul 2026 07:00:00 GMT